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Abstract
Background: Implementation of medical interventions may vary with organization and available capacity. The
influence of this source of variability on the cost-effectiveness can be evaluated by computer simulation following
a carefully designed experimental design. We used this approach as part of a national implementation study of
ultrasonographic infant screening for developmental dysplasia of the hip (DDH).
Methods: First, workflow and performance of the current screening program (physical examination) was analyzed.
Then, experimental variables, i.e., relevant entities in the workflow of screening, were defined with varying levels to
describe alternative implementation models. To determine the relevant levels literature and interviews among
professional stakeholders are used. Finally, cost-effectiveness ratios (inclusive of sensitivity analyses) for the range of
implementation scenarios were calculated.
Results: The four experimental variables for implementation were: 1) location of the consultation, 2) integrated
with regular consultation or not, 3) number of ultrasound machines and 4) discipline of the screener. With
respective numbers of levels of 3,2,3,4 in total 72 possible scenarios were identified. In our model experimental
variables related to the number of available ultrasound machines and the necessity of an extra consultation
influenced the cost-effectiveness most.
Conclusions: Better information comes available for choosing optimised implementation strategies where
organizational and capacity variables are important using the combination of simulation models and an
experimental design. Information to determine the levels of experimental variables can be extracted from the
literature or directly from experts.
Background
Implementing new technologies in organizations may
not be straightforward and simple. Not only will new
technology affect the organization itself but many times
the external environment of the organization as well [1].
Nowadays, also the economics of implementation as
such are being considered more and more [2-4]. In
practice, however, only one or two implementation stra-
tegies a priori considered feasible by the stakeholders
are taken into account for (economic) evaluation. This
limitation is largely due to financial and practical
constraints to analyze more strategies. Mostly this
implies leaving a number of potentially interesting and
viable scenarios unexplored.
To prepare for a wider implementation of a new
screening modality regarding developmental dysplasia of
the hip (DDH) in Dutch infant health care centers
(IHC) we will first evaluate different implementation
strategies. Earlier studies have shown that the current
screening strategy based on physical examinations and
identification of known risk factors leads to less favor-
able outcomes and waste of scarce health care resources
compared to ultrasound (US) screening. On the other
hand, reviews have also shown that there is doubt
regarding the effectiveness since over treatment may
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occur [5,6]. Implementing US screening is expected to
lead to lower referral rates to specialists. The Dutch
Soundchec 1 study showed that US screening would be
most (cost-) effective at the age of three months [7].
The Soundchec 1 study assessed which strategy was
(cost-) effective compared to current screening. The
strategies that were studied were selective screening, i.e.,
only children with risk factors for DDH, and general
ultrasound screening at the age of one, two and three
months. Based on this result, an implementation study
referred to as the Soundchec 2 study, was launched to
find and solve problems associated with future nation-
wide introduction of US screening. In total 4600 chil-
dren will be invited for US screening for an
implementation study in two different regions [8]. In
order to facilitate national implementation of the
screening program within the current health care system
information on possible risks, benefits, quality and costs
of US screening for detecting DDH should be assessed.
By modeling a number of implementation strategies
we expected to identify potentially viable implementa-
tion strategies, which may subsequently be subjected to
more elaborate experimentation. Our ultimate objective
was to explore various implementation models for US
screening in the current system and simultaneously esti-
mate the cost-effectiveness thereof. Using an experimen-
tal design we explicitly assessed how input variables
affect the outcome such as cost-effectiveness [9]. To see
which of the scenarios presented in the experimental
design performed best, a system analysis can be con-
ducted using a simulation model [9].
Methods
We used an experimental design with the subsequent
steps presented in Additional file 1: Table S1 [10]. We
began by analyzing the existing workflow and then
defined the relevant performance measures. Next alter-
native workflow scenarios were conceived during focus
group interviews. The software used to actually build
the model was ARENA [11]. Finally, through experi-
mentation with the alternative scenarios, those yielding
optimal performance could be identified. A societal per-
spective was used for the analysis which means that
costs for all potential payers are considered. Thus using
the simulation model we were able to estimate the
expected effects of all scenarios and it became clear
which factors influenced the outcomes most. Based on
the results from the simulation model the best perform-
ing alternatives may be selected, or possibly new further
improved scenarios may be drawn up. The overall
results may be used directly by policy makers or can be
used in additional implementations studies. The exami-
nation protocol of the Soundchec 2 study was reviewed
by the Medical Ethical Boards which judged that
approval was not necessary because no experimental
tests subject to the law on medical scientific research
were applied on humans.
Results
Step 1. Define performance measures
The variation between scenarios was reflected in the
variation of the cost per screen detected child which
was calculated for each scenario. A societal perspective
was used for the analysis which means that costs for all
potential payers are considered.
Costs for diagnosis, referral, treatment of dysplasia of
the hip, and time costs for the parents were included.
The relevant clinical outcome was defined as a child
detected and treated with treatment occurring within a
year after diagnosis (true positives of screening). In
essence, we summed and compared all the costs
incurred for the screening and treatment according to
the various scenarios and divided these by additional
number of children detected and treated. We also
included the cost of the missed cases and false positives.
Step 2 and 3. Analyze the performance of the existing
workflow: ‘Current and new strategy for detecting DDH’
In the Netherlands the current strategy for detecting
children with DDH consists of history taking and physi-
cal examination during routine consultation at the
infant health care centers (IHC) organized by youth
health care organizations. Parents visit the IHC at regu-
lar intervals and consultation either the nurse or the
physician. At the age of 1, 3, 6, 9 and 14 months the
consultation with the physician comprises identification
of risk factors and a physical examination of the hips. In
case of a positive test result, the child is referred to a
general practioner (GP). The GP will repeat the tests
performed by the IHC physician and will generally refer
the child to the radiology department or an orthopedic
surgeon. In an outpatient setting an ultrasound (US)
and/or X-ray and an orthopedic examination are per-
formed to determine whether DDH is present. In almost
84% of the children referred the presence of DDH is
refuted based on these specialist exams [7,12].
The new screening strategy requires that US examina-
tions of the infants’ hips are performed on the hips at
the age of three months. According to the principles of
Graf hips can be classified in six classes (type 1, 2b, 2c,
D, 3 and 4) where type 1 is normal and type 4 complete
luxation of the hip [13]. IHC-nurses, IHC physicians
and radiographic technicians (RT) who work at the IHC
may potentially qualify as screeners. These disciplines
were trained to perform the examinations. However, the
selection of disciplines performing the US examination
may influence the cost-effectiveness in two ways. If phy-
sicians should appear better at performing the
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examinations this implies increased costs in terms of
wages but on the other hand this might imply higher
effectiveness. Also, at an organizational level the cost-
effectiveness attained may be influenced by the available
capacity of screening personnel. This also applies to
actual rooms and equipment required to perform the
US examinations, training capacity, planning etc.
Regardless of the screening strategy there will be chil-
dren who have a higher risk of DDH. In the current
screening, all children whose parents during history tak-
ing state that one of the known risk factors is present
are sent to their GP and/or an orthopedic surgeon
regardless of the results of the physical examination. In
the situation where US screening is implemented, we
presumed that only those with a positive screening
result would be referred to a medical specialist, i.e.,
instead of acting on possible risk factors being present.
In table 1 the values in terms of missed cases, false posi-
tives and current screening and US-screening are given.
Step 4 and 5. Brainstorm about improvement, define
alternatives
By exploring changes in cost-effectiveness ratios we
could actually explore whether alternatives values of the
experimental variables (input) might be defined in such
a way that these remained plausible. The next step was
defining alternative implementation scenarios. We used
the ideas and comments which had been stated in focus
group interviews among stakeholders such as policy-
makers, managers in the IHC and screeners (physicians,
nurses and radiographic technicians). The choices for
these groups were based on the evaluation of the
Soundchec 2 project team. For each of these groups of
professionals separate interviews took place. In each
group four to eight persons participated. The purpose
for the interviews was to discuss possible limitations
and opportunities for the implementation of ultrasound
screening. These interviews provided important insight
regarding the definition of the experimental variables,
and also for performance measures. The complete arti-
cle describing the focus group interviews will be pub-
lished by the project team at a later phase.
Important performance measures defined were the
attendance rate and the quality of screening A high
attendance is critical for effective screening [14]. This
performance measure will provide important informa-
tion for the policy makers and the IHCs. Attendance in
rural areas may be different from that in urban areas
[15]. In rural areas people need to travel more because
of the spread of IHCs, which likely influences atten-
dance. On the other hand, in urban areas more people
who have different cultural background reside, which
may again influence the attendance rate. Another
important aspect of screening which can influence the
attendance rate is the organizer of the screening. The
interviewees suggested that screening should be planned
and conducted by an easy access organization which is
familiar to parents. The quality of the screening needs
to be compared with the current screening strategy. In a
previous study (Soundchec 1) the rates of missed cases,
treated and false positives were established [7]. Quality
of screening is an important outcome measure since
missed cases and false positives will influence the cost-
effectiveness.
Ideas that were brought forward for defining the
experimental variables were:
- availability of US-machines at every IHC
- implementation of the screening outside the IHC-
organizations
- consultation in evening hours
- implementation of the screening combined with
routine three month consultation, this would imply
at every IHC an US machine
- guaranteed high quality screening
- premise to call it screening is a high attendance,
which may be achieved through organization of the
screening close to the residence of parents
- influence of travel distance
- no purchase of US machines, but make use of
available US machines in other settings, e.g. in
obstetric centers.
From these global ideas four experimental variables
were derived which were considered to be pivotal for
the organization of ultrasound screening at IHCs. These
variables were subsequently used for experimentation
(table 2).
Based on these experimental variables, 72 possible sce-
narios can be drawn up. With the following assump-
tions, all scenarios were run in a simulation model:
1. If the screeners are employees currently working in
the IHC and/or the location of the screening is in build-
ings owned by the IHC, the screening is organized by
the IHC.
2. An integrated consultation implies a regular three
month consultation comprising an US examination.
When the screener is a radiographic technician or a
Table 1 Performance measures of the current screening
and the US-screening at the age of three months
Item Current screening US-screening
Missed cases 0.9% 0.6%
False positives 16.5% 1.3%
True positives 2.8% 3.2%
Percentages reflect the number of missed cases, false positives and true
positives as proportion of the total number of screened children.
Source [7]
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medical specialist, the infant health care physicians have
to be present at the location of screening to perform the
regular IHC consultation.
3. An integrated consultation with an infant health
care nurse as screener, means that infant health care
physicians will delegate their tasks in the regular three
month consultation to the infant health care nurse.
Delegation (substitution) of tasks under specified condi-
tions is increasingly applied in IHC [16,17].
Step 6. Experimentation with alternatives
Simulation model
The simulation model was build in ARENA [11]. Each
scenario was evaluated using sequences where patients
go to different stations defined by the sequence.
To model each of the 72 scenarios the levels for each
of the experimental variables were set. The levels were
set in accordance with expert opinion and data gathered
from IHC organizations. Besides the levels of the experi-
mental variables, the attendance rate and the quality of
screening examinations were quantified. This was
achieved using data available from IHC-organizations
(attendance rate and cost price) and expert opinion
(quality of screener). Other information needed to run
the model was based on the reports of the Soundchec 1
study [7], Dutch guideline for cost-effectiveness studies
[18], IHC-organization reports [15]and expert opinion.
The population simulated repeatedly comprised 2300
children expected to visit the IHC at regular time inter-
vals over a period of 18 months. This figure corresponds
with our ongoing implementation study. We excluded
the children who were referred and treated in their first
three months of life.
Quality and attendance rate
The quality of the screener is defined in terms of cases
missed (false negatives) and false positives, both as a
proportion of the total number of screened children.
Since only the proportions were known for radiographic
technicians (Soundchec 1 study), we set the proportions
for IHC physicians, IHC nurses and medical specialists
by expert opinion (Table 3).
Attendance rate was based on three participating orga-
nizations in the screening program. One organization in
a rural area and two organizations in an urban/suburban
area. For the rural area we used an attendance rate of
90% and for the urban area a rate of 85%. The re-atten-
dance rate (after a reminder) for the urban area was
estimated to be 80% and 90% for the rural area.
Cost items
With regard to the relevant estimates of cost items tra-
vel time is based on the Dutch guideline for CE analyses
[18]: 0.20 per kilometer by car or public transportation.
The travel distance to the different locations are 4-7
kilometers for IHC and ten for external locations [15].
Estimates of treatment costs were based on the Sound-
chec 1 study [7-18]. Treatment costs were included for
each Graf type. Also the treatment cost of current
screening after one and two months were based on this
study. For this period, treatment costs for Graf type 2a
were included since this type is only given to infants up
to two months of age. The cost of false positives in cur-
rent screening consisted of one hospital visit including
the cost of absence of work of the parents (€61 + €36).
In the model, the salaries were adjusted when screening
was done in evening hours (35% extra costs) and when
an extra consultation took place (double the salary costs
and travel time).
For cost of training we assumed that also medical spe-
cialists would need training since many of them do not
know how to perform US-screen for DDH and the set-
ting is different. We further assumed two day training
sessions lasting eight hours for the calculation. We used
the average salary of the four screener types plus
(16 hours * €73) an additional amount for salary of the
instructors and material (€ 130). These numbers were
justified by expert opinions who give training to radio-
graphic technicians.
For the costs of depreciation of the machine we calcu-
lated the annuity for the total period of five years with
Table 2 Experimental variables
Experimental
variables
A. Number of portable
US machines
1. As many as necessary US machines
2. Limited number of US machines
3. Externally organized (no US machines
purchased)
B. Consultation 1. Integrated consultation with regular
consultation at the age of three months
2. Extra consultation
C. Screener 1. Infant health care physician
2. Infant health care nurse
3. Radiographic technician (RT)
4. Medical specialist (radiologist or orthopedic
surgeon)
D. Location and time 1. Daytime at IHC
2. Organized in buildings not owned by IHC
(external)
3. Organized in evening hours at IHC.
Table 3 Quality of screening result for different screener
type
Experimental variable False positives Missed cases
Infant health care physician 1.4% 0.6%
Infant health care nurse 1.5% 0.7%
Radiographic Technician[19] 1.3% 0.6%
Medical specialist 0.6% 0.3%
Presented percentages reflect the number of missed cases or false positives
as proportion of the total number of screened children.
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an interest rate of 5% (€ 7560) [18]. Each machine costs
€ 32725, the insurance per year costs € 1000. We also
included maintenance costs of 8% of € 32725 (€ 2618)
[18]. The total costs per year are therefore € 11178,
which resulted in an average of € 5 per child (2300 chil-
dren). In table 4 all items are presented together with
the point estimates and sources. Prices were adjusted
using the price index rate (statline.cbs.nl) for the year
2006.
Explanation quantification levels of experimental variables
A. Number of Ultrasound machines The scenarios for
the levels pertaining to the number of US machines are
defined in accordance with the following assumptions:
- Many machines: average number of IHC assumed
to be efficient is seven based on literature and expert
opinion [15],
- Limited: one US machine, which means one salary
compartment and one overhead for each cycle.
- None: buildings will be used where US machines
are already available, like in an obstetrics center or
in a multilevel health care facility center.
B. Consultation For one consultation at the IHC par-
ents incur one hour productivity loss. For an extra con-
sultation this would mean in total two hours of
productivity loss for the diagnosis and detection of
DDH. Extra travel time cost was also included for an
extra consultation.
C. Screener For each screener type the salary was calcu-
lated for ten minutes. For each screener, the variability
of the quality of screening was included with the use of
expert opinion.
D. Location For each location attendance rate, travel
time and costs were included. Extra cost for the evening
hours was 35% of the average salary [18]. For an exter-
nal location rent needed to be paid.
Step 7. Select best alternatives
For each of the 72 scenarios we calculated the cost per
screen detected child. For each scenario we divided the
total cost by the number of true positives which gave us
the cost effectiveness-ratio (CE-ratio). We divided the
results in terms of iCERS in quartiles of cost-effective-
ness (CE_A to CE_D), thus each group included 18 sce-
nario’s (see table 5). For each of the four groups we
estimated the frequency of the experimental variables.
For experimental variable A we saw that the frequency
for level 1 (many machines are bought) in the least cost-
effective scenario’s (group CE_ D) was high. For level 2
(limited machines are bought) we saw a slightly higher
frequency in group CE_B and for level 3 (no machines
are bought) a higher frequency in group CE_A.
Table 4 Cost items, source and values
Item Source Value
IHC physician IHC - CAO fwg 65 € 75 per hour
IHC nurse IHC - CAO fwg 45-50 € 42 per hour
Radiographic technician Hospital CAO € 70 per hour
Radiologist Hospital CAO € 106 per hour
Ultrasound at hospital Soundchec 1 € 61 per hour
Treatment missed case Average of type 2, D,3 and 4 € 1217
Travel time Dutch guideline for CE-analyses (price per kilometer) € 0.20
Training Soundchec 2 € 1300
Treatment Soundchec 1
Percentages:
after first consultation at IHC. - € 571
after US type 2b/c 1.4% - € 897
after US type D 1.5% - € 717
after US type 3/4 0.5% - € 2043
Referral percentage first consultation Soundchec 1 0.61%
Treated after first consultation IHC Soundchec 1 0.31%
Time Parents Dutch guideline for CE analyses € 36 per hour
Use US machine Dutch guideline for CE studies € 5 per child
Overhead evening hours 35% of average salary of screeners € 5 euro per child
Table 5 CE-groups
Group Cost-effectiveness range
CE_A low 3231 - 3469
CE_B moderate 3473 - 4188
CE_C intermediate 4190 - 4549
CE_D high 4794 - 5310
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Figure 1
For Experimental variable B consultation the frequencies
were mostly located in the most cost effective quartiles
for level one (integrated consultation). Level 2 (extra
consultation) was mostly located in the least cost effec-
tive quartiles.
Figure 2
Figure 3
For experimental variable C a less clear pattern could be
revealed. The frequencies for level 1 (infant health care
physicians) were high in group CE_C For level 2
(nurses) we saw a high frequency in group CE_A and
for level 4 (medical specialist) a high frequency in group
CE_B.
Figure 4
For level 1 (daytime in IHC centers) of experimental
variable D we found that the frequency was highest in
group CE_B and for level 2 (rented buildings) in group
CE_C. Level 3 (evening sessions) was almost equally dis-
tributed among the four groups, but had the highest fre-
quency in group CE_D.
Table 6 Least and most cost-effective scenarios
The five most cost-effective scenarios (47, 29, 55, 49 and
64) and the least cost-effective scenarios (61, 15, 21, 69
and 9) are presented in table 6. The difference in cost
per screen detected child between the least and the
most cost-effective scenarios is approximately 2000
euro. This difference is due to the fact that in most
cost-effective scenarios no US machines were bought
(level 3 for experimental variable A) and screening took
place in buildings currently owned by the IHC (level 1
experimental variable D). The screening is done by one
of the four screener types and in three cases the screen-
ing takes is done by a nurse. All five cost-effective sce-
narios take place in an integrated consultation. For the
least cost-effective scenarios we noted that there were
many machines bought, the screening took place in a
building that had to be rented sometimes or in the eve-
ning with additional salary costs and an extra consulta-
tion occurred.
Discussion
Better information comes available for selecting opti-
mised implementation strategies where organizational
and capacity variables are important using the combina-
tion of simulation models and an experimental design.
Information to determine the levels of experimental
variables can be extracted from the literature or directly
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Figure 1 Experimental variable A Number of ultrasound machines. Quartiles of cost-effectiveness (CE_A to CE_D) ranging from most cost-
effective (group CE_A) to least cost-effective (group CE_D). Levels used: 1. As many as necessary US machines, 2. Limited number of US
machines and 3. Externally organized (no US machines purchased).
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Figure 2 Experimental variable B Consultation. Quartiles of cost-effectiveness (CE_A to CE_D) ranging from most cost-effective (group CE_A)
to least cost-effective (group CE_D). Levels used 1. Integrated consultation with regular consultation at the age of 3 months and 2. Extra
consultation.
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from experts. The variability and their interaction of
independent variables on outcomes, for example cost-
effectiveness, can be better revealed by analysing many
possible strategies.
Early detection and treatment of DDH are important.
Current screening methods using risk identification and
physical examinations result in considerable numbers of
missed cases and high proportions of false positives.
Ultrasound screening of the infant hip was shown to be
a cost-effective alternative screening method. In the
Netherlands ultrasound screening may be organized in
the current infant health care centers where children
have regular consultations with physicians and nurses.
How to best organize i.e., optimize screening for
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Figure 3 Experimental variable C Screener. Quartiles of cost-effectiveness (CE_A to CE_D) ranging from most cost-effective (group CE_A) to
least cost-effective (group CE_D). Levels used 1. Infant health care physician, 2. Infant health care nurse, 3. Radiographic technician (RT) and 4.
Medical specialist (radiologist or orthopedic surgeon).
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Figure 4 Experimental variable D Location. Quartiles of cost-effectiveness (CE_A to CE_D) ranging from most cost-effective (group CE_A0 to
least cost-effective (group CE_D). Levels used 1. Daytime at IHC, 2. Organized in buildings not owned by IHC (external) and 3. Organized in
evening hours at IHC.
Table 6 Five Least en most cost-effective scenarios
scenarios Experimental variable A
Ultrasound machines
Experimental variable B
Consultation
Experimental variable C
Screenertype
Experimental variable D
Location/time
Cost/Effect
47 3 1 2 1 3231
29 2 1 2 1 3273
55 3 1 4 1 3299
49 3 1 3 1 3321
64 3 1 2 3 3329
61 1 2 4 2 5159
15 1 2 2 2 5159
21 1 2 3 2 5249
69 1 2 4 3 5256
9 1 2 1 2 5310
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detecting DDH in terms of cost-effectiveness may not be
revealed by choosing and implementing just one imple-
mentation strategy in an experimental setting. The use
of a hypothetical experimental design in combination
with a simulation model allows researchers to efficiently
estimate the potential cost-effectiveness of the many
possible implementation strategies or scenarios. Impor-
tant information regarding the levels of the parameters
in an experimental design may be derived from expert
opinion and literature.
Four experimental variables with corresponding levels
were set. In total 72 scenarios were evaluated using this
design. The 4 experimental variables were defined for
the number of US machines (A), the type of consulta-
tion (B), type of screener (C) and the location (D). The
72 cost-effectiveness ratios were divided in four groups,
ranging from least cost-effective to most cost-effective.
For experimental variable A we saw that for each level
the highest frequency was located in a different cost-
effectiveness quartile. This can be explained by the fact
that for each additional US machine, training of addi-
tional screeners would be required. The levels of experi-
mental variable B were right censored for level 1 and
left censored for level 2. This means that an extra con-
sultation was in the group for low cost-effectiveness and
vice versa for level 2. This can be explained by the addi-
tional indirect costs that have to be made for an extra
consultation (travel cost and absence of work). For
experimental variable C Screener we see that the fre-
quency for the different quartiles is different for each of
the four levels. This can be explained by the fact that
nurses and radiographic technicians may be less expen-
sive but also perform less accurate. Medical specialists
are more expensive but presumably more accurate. For
the two expensive screener types (IHC-physician and
medical specialist) the frequencies are the highest in
group CE_C and CE_D. For nurses (level 2) the highest
frequency is in group CE_A. For each of the levels of
experimental variable D we saw that each level had the
highest frequency in different groups in terms of cost-
effectiveness. This can be explained by the difference in
overhead costs or rent that for each location has to be
paid. It is therefore straightforward that level one is
located in the most cost-effectiveness groups CE_A and
CE_B since no additional costs need to be made.
The five most cost-effective scenarios had in common
that none included the level ‘many US machines’ and
externally organised in buildings that have to be rented.
On the other hand, all five included an integrated con-
sultation. The five least CE-scenarios had in common
that they all included the level many US machines, an
extra consultation and organisation in evening times or
external buildings. In our model the experimental vari-
ables related to the number of US machines in
combination with an extra consultation affected cost-
effectiveness the most.
With regard to the information used and the underly-
ing assumptions we recognize that for nationwide imple-
mentation of screening the final parameter estimates may
be different from those currently used. Also, to reflect
uncertainty regarding point estimates (based on expert
opinion), distributions around point estimates can be
used. In this study the (number of children) detected and
treated within a year were used for the outcome-analysis.
When using cost-effectiveness analysis as primary out-
come measure, QALY measurements should preferably
be used. When using QALY as a measure of effect this
facilitates comparisons between other cost-effectiveness
analysis or maximum willingness to pay of a society.
Because no other data were available, we used the data
pertaining to the current screening strategy. The ongoing
implementation study started by our study group will
end in 2009. This study will yield accurate and within
trial data on quality difference between the different
types of screeners, attendance rate and the interaction
effects between variables. The uncertainty with regard to
the actual effectiveness of treatment of DDH has not
been modeled. The cost for society of possible over treat-
ment is in fact impossible to calculate since no rando-
mized control trial has been done to evaluate the
effectiveness of treatment on DDH. Children who are
incorrectly referred (false positives) might receive treat-
ment. This study assumes that false positives did not
undergo treatment. No data are available on the number
of children offered treatment after ultrasound screening.
The simulation model described in this article was used
to assess variation between scenarios not to estimate the
exact cost-effectiveness of the scenarios.
Conclusions
Further research is needed for the analyses of local
capacities to optimally organize screening. These results
will be presented later using a discrete-event simulation
model where the competition for resources will be
included. As an overall recommendation we believe that
an experimental design and interviews with experts may
restate and be used for the definition for alternative sce-
narios. The five candidate scenarios appear promising
and should be subjected to further simulation and prac-
tical experimentation.
Additional file 1: Steps in experimental design. A table showing 7
steps in an experimental design.
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